References and Notes
1a
Wang L.
Schultz PG.
Angew.
Chem. Int. Ed.
2005,
44:
34
1b
Medical
Chemistry of Bioactive Natural Products
Liang X.-T.
Fang W.-S.
Wiley;
Hoboken
NJ:
2006.
p.35-72
1c Kim RM, Kahne DE, and Chapman KT. inventors; PCT Int. Appl. WO 2000069893.
; Chem. Abstr. 2000, 134, 5162
1d
Shang G.
Yang Q.
Zhang X.
Angew.
Chem. Int. Ed.
2006,
45:
6360
1e
Williams RM.
Hendrix JA.
Chem.
Rev.
1992,
92:
889
1f
Stammer CH.
Tetrahedron
1990,
46:
2231
1g
Heimgartner H.
Angew.
Chem., Int. Ed. Engl.
1991,
30:
238
2
Shendage DM.
Fröhlich R.
Haufe G.
Org.
Lett.
2004,
6:
3675
3a
Basavaiah D.
Rao AJ.
Satyanarayana T.
Chem. Rev.
2003,
103:
811
3b
Yeo JE.
Yang X.
Kim HJ.
Koo S.
Chem. Commun.
2004,
236
3c
Luo S.
Wang PG.
Cheng J.-P.
J.
Org. Chem.
2004,
69:
555
3d
Aggrawal
VK.
Patin A.
Tisserand S.
Org. Lett.
2005,
7:
2555
3e
Lee KY.
Gowrisankar S.
Kim JN.
Tetrahedron
Lett.
2005,
46:
5387
3f
Wasnaire P.
Wiaux M.
Touillaux R.
Markó IE.
Tetrahedron
Lett.
2006,
47:
985
3g
Basavaiah D.
Rao KV.
Reddy R.
J.
Chem. Soc. Rev.
2007,
36:
1581
3h
Shi Y.-L.
Shi M.
Eur. J. Org. Chem.
2007,
2905
3i
Masson G.
Housseman C.
Zhu J.
Angew. Chem.
Int. Ed.
2007,
4614
3j
Singh V.
Yadav GP.
Maulik PR.
Batra S.
Tetrahedron
2008,
64:
2979
4a
Kundu MK.
Sundar N.
Kumar SK.
Bhat SV.
Biswas S.
Valecha N.
Bioorg.
Med. Chem. Lett.
1999,
9:
731
4b
Basavaiah D.
Hyma RS.
Kumaragurubaran N.
Tetrahedron
2000,
56:
5905
4c
Kaye PT.
Musa MA.
Synth.
Commun.
2003,
33:
1755
4d
Patra A.
Batra S.
Bhaduri AP.
Khanna A.
Chander R.
Dikshit M.
Biosci. Med. Chem.
2003,
11:
2269
4e
de Souza ROMA.
Meireles BA.
Aguiar CS.
Vasconcellos M.
Synthesis
2004,
1595
4f
Vasconcellos M.
Silva TMS.
Camara CA.
Martins RM.
Lacerda KM.
Lopes HM.
Pereira VLP.
de Souza ROMA.
Crespo LTC.
Pest. Manage. Sci.
2006,
62:
288
4g
de Souza ROMA.
Pereira VLP.
Muzitano MF.
Falcao CAB.
Rossi-Bergmann B.
Filho EBA.
Vasconcellos M.
Eur. J. Med. Chem.
2007,
42:
99
5a
Cho C.-W.
Kong J.-R.
Krische MJ.
Org. Lett.
2004,
6:
1337
5b
Singh V.
Saxena R.
Batra S.
J.
Org. Chem.
2005,
70:
353
5c
Ma S.
Yu S.
Peng Z.
Guo H.
J. Org. Chem.
2006,
71:
9865
5d
Singh V.
Batra S.
Eur. J. Org. Chem.
2007,
2970
5e
Gowrisankar S.
Kim SJ.
Lee
J.-E.
Kim JN.
Tetrahedron Lett.
2007,
48:
4419
5f
Lee HS.
Kim JM.
Kim JN.
Tetrahedron
Lett.
2007,
48:
4119
5g
Selvakumar N.
Kumar PK.
Shekar Reddy KC.
Chandra Chary B.
Tetrahedron
Lett.
2007,
48:
2021
6a
Yadav LDS.
Yadav S.
Rai VK.
Green Chem.
2006,
8:
455
6b
Yadav LDS.
Rai VK.
Synlett
2007,
1227
6c
Yadav LDS.
Rai VK.
Tetrahedron
Lett.
2008,
49:
5553
6d
Yadav LDS.
Rai VK.
Yadav BS.
Tetrahedron
2009,
65:
1306
7a
Yadav LDS.
Awasthi C.
Rai A.
Tetrahedron
Lett.
2008,
49:
6360
7b
Yadav LDS.
Patel R.
Srivastava
VP.
Synlett
2008,
1789
7c
Yadav LDS.
Awasthi C.
Tetrahedron
Lett.
2009,
50:
715
8
Vandenberg GE.
Harrison JB.
Carter HE.
Magerlein BJ.
Org.
Synth., Coll. Vol. V
1973,
946
9
Moorthy JN.
Singhal N.
J. Org. Chem.
2005,
70:
1926
10a
Basavaiah D.
Pandiaraju S.
Padmaja K.
Synlett
1996,
393
10b
Basavaiah D.
Satyanarayana T.
Org. Lett.
2001,
3:
3619
10c
Kabalka GW.
Venkataiah B.
Dong G.
Org. Lett.
2003,
5:
3803
10d
Yadav JS.
Gupta MK.
Pandey SK.
Reddy BVS.
Sarma AVS.
Tetrahedron
Lett.
2005,
46:
2761
10e
Nag S.
Pathak R.
Kumar M.
Shukla PK.
Batra S.
Bioorg.
Med. Chem. Lett.
2006,
16:
3824
11a
Chung YM.
Gong JH.
Kim TH.
Kim JN.
Tetrahedron
Lett.
2001,
42:
9023
11b
Du Y.
Han X.
Lu X.
Tetrahedron
Lett.
2004,
45:
4967
11c
Li J.
Wang X.
Zhang Y.
Tetrahedron
Lett.
2005,
46:
5233
11d
Singh V.
Yadav GP.
Maulik PR.
Batra S.
Tetrahedron
2006,
62:
8731
11e
Lee KY.
Gowrisankar S.
Lee YJ.
Kim JN.
Tetrahedron
2006,
62:
8798
12
Cho C.-W.
Krische MJ.
Angew. Chem. Int.
Ed.
2004,
43:
6689
13a
Trost BM.
Tsui HC.
Toste FD.
J. Am. Chem. Soc.
2000,
122:
3534
13b
Roy O.
Riahi A.
Henin F.
Muzart J.
Tetrahedron
2000,
56:
8133
13c
Kobalaka GW.
Dong G.
Venkataiah B.
Chen C.
J. Org. Chem.
2005,
70:
9207
13d
Nemot T.
Fukuyama T.
Yamamoto E.
Tamura S.
Fukuda T.
Matsumoto T.
Akimoto Y.
Hamada Y.
Hamada Y.
Org.
Lett.
2007,
9:
927
14
Shafiq Z.
Liu L.
Liu Z.
Wang D.
Chen Y.-J.
Org. Lett.
2007,
9:
2525
15
Basavaiah D.
Krishnamacharyulu M.
Hyma RS.
Sarma PKS.
Kumaragurubaran N.
J. Org. Chem.
1999,
64:
1197
16
Isolation of Intermediate
3a and its Conversion into the Corresponding N-Protected α-Amino
Acid 4a
To a well-stirred solution of MBH acetate 1 (2 mmol) in THF (10 mL), DABCO (0.4
mmol) was added and stirred for 30 min at r.t. followed by addition
of 2-phenyl-1,3-oxazol-5-one 2 (2 mmol)
and stirring at r.t. for 5.5 h (Table
[¹]
).
After completion of the reaction as indicated by TLC, the solvent
was evaporated under reduced pressure, H2O (20 mL) was
added, and the product was extracted with EtOAc (3 × 20
mL). The combined organic layer was washed with brine (25 mL), dried
over MgSO4, filtered, and evaporated to dryness. The
crude product thus obtained was purified by column chromatography
to afford an analytically pure sample of a single diastereomer 3a (Table
[¹]
).
The product 3a (2 mmol) was dissolved in
THF (10 mL), then H2O (5 mL) was added, and the reaction
mixture was stirred at r.t. for 3 h. After completion of the reaction,
H2O (10 mL) was added and the combined organic layer
was extracted with CH2Cl2 (3 × 10
mL), concentrated under reduced pressure, and the crude product 4a thus obtained was recrystallized from
EtOH to afford an analytically pure sample of 4a quantitatively.
Characterization Data for the Isolated Intermediate
3a
Pale yellow solid; yield 89%; mp 199-201 ˚C.
IR (KBr): νmax = 3039,
2217, 1773, 1605, 1579, 1459, 1316 cm-¹.
¹H
NMR (400 MHz, CDCl3/TMS): δ = 4.19
(d, 1 H, J
ArCH,NCH = 11.6
Hz, ArCH), 4.41 (d, 1 H, J
ArCH,NCH = 11.6 Hz, NCH), 5.80 (s, 1 H, =CH), 5.92
(s, 1 H, =CH), 7.17-7.73 (m, 10 Harom). ¹³C
NMR (100 MHz, CDCl3/TMS): δ = 39.1, 63.8,
117.2, 119.8, 126.5, 127.3, 128.1, 129.2, 129.8, 130.6, 131.3, 132.0,
133.1, 165.9, 172.8. MS (EI): m/z = 302 [M+]. Anal.
Calcd for C19H14N2O2:
C, 75.48; H, 4.67; N, 9.27. Found: C, 75.19; H, 4.31; N, 9.46.
17
General Procedure
for the One-Pot Synthesis of N-protected α-Amino Acids
4
The MBH acetate 1 (2 mmol)
was dissolved in THF (10 mL) DABCO (0.4 mmol) was added, and the
reaction mixture was stirred for 30 min at r.t. Thereafter, 2-phenyl-1,3-oxazol-5-one
(2, 2 mmol) was added to the reaction mixture, and
it was stirred at r.t. for 6-8 h followed by addition of H2O
(5 mL) and stirring was continued for the next 1-2 h at r.t.
(Table
[²]
). After
completion of the reaction as indicated by TLC, the solvent was
evaporated under reduced pressure, H2O (10 mL) was added
to the reaction mixture and extracted with CH2Cl2 (3 × 10
mL), the combined organic phase concentrated under reduced pressure,
and the crude product 4 thus obtained was
recrystallized from EtOH to afford a diastereomeric mixture (>92:<8;
in the crude products the ratio was >90:<10 as
determined by ¹H NMR spectroscopy). The product
on second recrystallization from EtOH furnished an analytically
pure sample of a single diastereomer 4 (Table
[²]
). On the basis of comparison
of J values to literature ones,³j,¹¹e the anti stereochemistry was assigned to 4, as the coupling constant (J
NCH,ArCH = 11.6-11.9
Hz) for 4 was greater than that for very
minor (<6%) syn diastereomer, J
NCH,ArCH = 3.8
Hz. Characterization Data of Representative
Compounds 4
Compound 4a:
pale yellow solid; yield 90%; mp 143-145 ˚C.
IR (KBr): νmax = 3355-2659,
3044, 2218, 1677, 1601, 1588, 1453, 1319 cm-¹. ¹H
NMR (400 MHz, CDCl3/TMS): δ = 4.47
(d, 1 H, J
ArCH,NCH = 11.8
Hz, ArCH), 4.91 (d, 1 H, J
ArCH,NCH = 11.8
Hz, NCH), 5.79 (s, 1 H, =CH),
5.96 (s, 1 H, =CH), 7.23-7.89 (m, 10 Harom),
8.19 (br s, 1 H, NH, exchangeable with D2O), 11.21 (br
s, 1 H, OH, exchangeable with D2O). ¹³C
NMR (100 MHz, CDCl3/TMS): δ = 39.5, 60.1,
117.3, 120.3, 125.9, 126.7, 127.9, 129.3, 130.0, 130.8, 131.5, 132.3,
133.5, 171.2, 173.8. MS (EI): m/z = 320 [M+]. Anal.
Calcd for C19H16N2O3:
C, 71.24; H, 5.03; N, 8.74. Found: C, 71.49; H, 4.71; N, 9.12.
Compound 4i: pale yellow solid; yield 86%;
mp 172-174 ˚C. IR (KBr): νmax = 3357-2663,
3451, 3055, 2213, 1676, 1599, 1581, 1455, 1321 cm-¹. ¹H
NMR (400 MHz, CDCl3/TMS): δ = 4.41
(d, 1 H, J
ArCH,NCH = 11.9
Hz, ArCH), 4.95 (d, 1 H, J
ArCH,NCH = 11.9
Hz, NCH), 5.75 (s, 1 H, =CH), 5.98
(s, 1 H, =CH), 7.19-7.58 (m, 7 Harom),
7.71-7.87 (m, 2 Harom), 8.22 (br s, 1 H, NH,
exchangeable with D2O), 11.20 (br s, 1 H, OH, exchangeable
with D2O). ¹³C NMR (100 MHz,
CDCl3/TMS): δ = 39.2,
60.3, 117.7, 120.9, 124.8, 125.5, 126.2, 127.0, 128.1, 129.2, 130.3,
131.0, 132.6, 133.7, 142.5, 171.5, 174.1. MS (EI): m/z = 398 [M+].
Anal. Calcd for C19H15BrN2O3:
C, 57.16; H, 3.79; N, 7.02. Found: C, 57.54; H, 3.98; N, 6.79.